✦ LIBER ✦

Topotecan and cisplatin in combination with concurrent twice-daily chemoradiation in limited disease small cell lung cancer—a Danish Oncological Lung Cancer Group (DOLG) phase II trial

✍ Scribed by SORENSEN, M; LASSEN, U; PALSHOF, T; JENSEN, B; JOHANSEN, J; JENSEN, P; LANGER, S

Book ID: 119319786
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 191 KB
Volume: 60
Category: Article
ISSN: 0169-5002
DOI: 10.1016/j.lungcan.2007.09.022

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P-797 Combination chemotherapy including

P-797 Combination chemotherapy including topotecan concurrentlywith twice-daily radiotherapy in limited SCLC. A phase II trial of the Danish Oncological Lung Cancer Group (DOLG)

✍ Sorensen, M.; Lassen, U.; Langer, S.; Palshof, T.; Bjerregaard, B. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 139 KB

Cisplatin/etoposide chemotherapy combine

Cisplatin/etoposide chemotherapy combined with twice daily thoracic radiotherapy for limited small-cell lung cancer: A clinical Phase II trial

✍ Gui-Yuan Chen; Guo-Liang Jiang; Li-Juan Wang; Hao Qian; Xiao-Long Fu; Huajun Yan 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 112 KB

Phase II trial of irinotecan and cisplat

Phase II trial of irinotecan and cisplatin with early concurrent radiotherapy in limited-disease small-cell lung cancer

✍ Joo Hyuk Sohn; Yong Wha Moon; Chang Geol Lee; Gwi Eon Kim; Kyung Young Chung; Jo 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 2 views

## Abstract ## BACKGROUND. A Phase II trial of irinotecan and cisplatin (IP) with early concurrent radiotherapy was performed in limited‐disease small‐cell lung cancer (LD‐SCLC) to evaluate the efficacy and toxicity. ## METHODS. For untreated LD‐SCLC patients, irinotecan (60 mg/m^2^, Days 1, 8,

Concurrent cisplatin/etoposide chemother

Concurrent cisplatin/etoposide chemotherapy plus twice daily thoracic radiotherapy in limited stage small cell lung cancer: a phase II study

✍ Mennecier, Bertrand; Jacoulet, Pascale; Dubiez, André; Westeel, Virginie; Bosset 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 79 KB

9116 A phase I/II clinical trial of topo

9116 A phase I/II clinical trial of topotecan in combination with cisplatin for extensive-disease small cell lung cancer

✍ Seto, T.; Ichinose, Y.; Nishiwaki, Y.; Kiura, K.; Sakai, H.; Shibuya, M.; Takeda 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 45 KB

P-776 Phase II trial of irinotecan and c

P-776 Phase II trial of irinotecan and cisplatin with concurrent radiotherapy in limited-disease small cell lung cancer

✍ Kim, J.; Moon, Y.; Sohn, J. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 141 KB